中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
7期
18-19
,共2页
庞淑光%叶胜捷%张文振%李泳焱%方声教%陈如俊
龐淑光%葉勝捷%張文振%李泳焱%方聲教%陳如俊
방숙광%협성첩%장문진%리영염%방성교%진여준
重组人生长激素%丹参注射液%烧伤%临床研究
重組人生長激素%丹參註射液%燒傷%臨床研究
중조인생장격소%단삼주사액%소상%림상연구
Recombinant human growth hormone (rhGH)%Danshen injection%Burn%Clinical study
目的评价重组人生长激素联合丹参注射液对重症烧伤的临床治疗效果.方法将120例严重烧伤患者,随机分为A组(观察组)和B组(对照组),每组60例.A组静脉滴注丹参注射液,B组注射相同体积的等渗盐水;两组给予皮下注射0.1mg/(kg?d)重组人生长激素治疗.疗程为14d.监测并记录两组患者的蛋白代谢及糖代谢,内毒素(LPS)、肿瘤坏死因子α(TNF-α)以及白细胞介素(IL-6)水平.结果治疗后7d与14d,观察组血红蛋白及血浆总蛋白均高于对照组,差异具有统计学意义(P<0.05);治疗后7d与14d,观察组LPS(脂多糖),TNF-α,IL=6均显著低于对照组(P<0.05).结论重组人生长激素联用丹参注射液对重症烧伤患者可发挥一系列的治疗作用,如促进蛋白质合成,抑制炎性反应,提高患者的免疫功能,降低患者感染率,进而可缩短患者的住院时间.治疗效果稳定可靠,优于单用重组人生长激素治疗.
目的評價重組人生長激素聯閤丹參註射液對重癥燒傷的臨床治療效果.方法將120例嚴重燒傷患者,隨機分為A組(觀察組)和B組(對照組),每組60例.A組靜脈滴註丹參註射液,B組註射相同體積的等滲鹽水;兩組給予皮下註射0.1mg/(kg?d)重組人生長激素治療.療程為14d.鑑測併記錄兩組患者的蛋白代謝及糖代謝,內毒素(LPS)、腫瘤壞死因子α(TNF-α)以及白細胞介素(IL-6)水平.結果治療後7d與14d,觀察組血紅蛋白及血漿總蛋白均高于對照組,差異具有統計學意義(P<0.05);治療後7d與14d,觀察組LPS(脂多糖),TNF-α,IL=6均顯著低于對照組(P<0.05).結論重組人生長激素聯用丹參註射液對重癥燒傷患者可髮揮一繫列的治療作用,如促進蛋白質閤成,抑製炎性反應,提高患者的免疫功能,降低患者感染率,進而可縮短患者的住院時間.治療效果穩定可靠,優于單用重組人生長激素治療.
목적평개중조인생장격소연합단삼주사액대중증소상적림상치료효과.방법장120례엄중소상환자,수궤분위A조(관찰조)화B조(대조조),매조60례.A조정맥적주단삼주사액,B조주사상동체적적등삼염수;량조급여피하주사0.1mg/(kg?d)중조인생장격소치료.료정위14d.감측병기록량조환자적단백대사급당대사,내독소(LPS)、종류배사인자α(TNF-α)이급백세포개소(IL-6)수평.결과치료후7d여14d,관찰조혈홍단백급혈장총단백균고우대조조,차이구유통계학의의(P<0.05);치료후7d여14d,관찰조LPS(지다당),TNF-α,IL=6균현저저우대조조(P<0.05).결론중조인생장격소련용단삼주사액대중증소상환자가발휘일계렬적치료작용,여촉진단백질합성,억제염성반응,제고환자적면역공능,강저환자감염솔,진이가축단환자적주원시간.치료효과은정가고,우우단용중조인생장격소치료.
@@@@Objective To evaluate the clinical efficacy of recombinant human growth hormone combined with Danshen injection in severely burned patients. Methods 120 cases of severely burned patients were randomLy divided into A group (rhGH and D.I. group) and B group (control group). Patients in group A were given Danshen injection and patients in group B the same volume of normal saline. Both groups were treated with rhGH injection [0.1mg/(kg?d), subcutaneous injection]. The treatment lasted for 14 days. Protein metabolism, glucose metabolism, LPS, TNF-α, IL-6 were assayed and compared between two groups. Results Compared with patients in group B, those in group A had significantly higher protein content and remarkably lower LPS, TNF-αand IL-6 (P<0.05). Conclusions The therapy of recombinant human growth hormone combined with Danshen Injection can treat severely burned patients in a number of ways:promoting protein synthesis, inhibiting inflammation, enhancing immunological function and reducing infection. The combined therapy is superior to rhGH therapy and can achieve better efficacy.